Compare BBIO & WBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBIO | WBS |
|---|---|---|
| Founded | 2015 | 1935 |
| Country | United States | United States |
| Employees | N/A | 4601 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 11.8B |
| IPO Year | 2019 | N/A |
| Metric | BBIO | WBS |
|---|---|---|
| Price | $67.48 | $72.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 25 | 15 |
| Target Price | ★ $86.33 | $73.64 |
| AVG Volume (30 Days) | ★ 2.8M | 2.7M |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.23% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $502,076,000.00 | N/A |
| Revenue This Year | $89.45 | $5.32 |
| Revenue Next Year | $73.78 | $5.89 |
| P/E Ratio | ★ N/A | $12.28 |
| Revenue Growth | ★ 126.26 | N/A |
| 52 Week Low | $38.57 | $50.66 |
| 52 Week High | $84.94 | $74.00 |
| Indicator | BBIO | WBS |
|---|---|---|
| Relative Strength Index (RSI) | 46.98 | 50.29 |
| Support Level | $62.37 | $71.13 |
| Resistance Level | $69.85 | $73.72 |
| Average True Range (ATR) | 2.77 | 0.63 |
| MACD | 0.10 | -0.04 |
| Stochastic Oscillator | 46.43 | 46.17 |
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
Webster Financial Corp is a full-service provider of financial services, offering commercial and consumer banking, mortgages, and investment advisory along with trust and wealth management services in Connecticut, New York, Rhode Island, Massachusetts, and Pennsylvania. The company's segment includes Commercial Banking, HSA Bank, and Consumer Banking. It generates maximum revenue from the Commercial Banking segment.